Clinical Trial Update: The Effect of Trimetazidine on Mitochondrial Function, Myocardial Performance, and Invasive Hemodynamics in Patients Diagnosed With Wild-Type Transthyretin Cardiac Amyloidosis [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating trimetazidine's impact on mitochondrial function, myocardial performance, and invasive hemodynamics in patients with wild-type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Drugs mentioned

• Trimetazidine (trimetazidine)

Snippet

Sponsor: Steen Hvitfeldt Poulsen | Conditions: Transthyretin Amyloid Cardiopathy, Mitochondrial Pathology | Phase 4 | Status: COMPLETED